A detailed history of Alberta Investment Management Corp transactions in Johnson & Johnson stock. As of the latest transaction made, Alberta Investment Management Corp holds 14,700 shares of JNJ stock, worth $2.14 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,700
Previous 194,170 92.43%
Holding current value
$2.14 Million
Previous $28.4 Million 91.61%
% of portfolio
0.02%
Previous 0.34%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$145.48 - $167.38 $26.1 Million - $30 Million
-179,470 Reduced 92.43%
14,700 $2.38 Million
Q2 2024

Aug 13, 2024

BUY
$144.38 - $157.78 $19.1 Million - $20.9 Million
132,570 Added 215.21%
194,170 $28.4 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $1.78 Million - $1.87 Million
-11,475 Reduced 15.7%
61,600 $9.74 Million
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $1.67 Million - $1.82 Million
11,475 Added 18.63%
73,075 $11.5 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $7.6 Million - $8.18 Million
-49,241 Reduced 44.42%
61,600 $10.2 Million
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $12.1 Million - $14.5 Million
-80,315 Reduced 42.02%
110,841 $17.2 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $25.7 Million - $28.8 Million
-160,412 Reduced 45.63%
191,156 $33.8 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $435,591 - $484,704
-2,700 Reduced 0.76%
351,568 $57.4 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $18.1 Million - $20.1 Million
-107,863 Reduced 23.34%
354,268 $62.9 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $7.03 Million - $7.99 Million
-44,477 Reduced 8.78%
462,131 $81.9 Million
Q4 2021

Feb 11, 2022

BUY
$155.93 - $173.01 $15.2 Million - $16.9 Million
97,467 Added 23.82%
506,608 $86.7 Million
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $10.2 Million - $11.3 Million
-63,000 Reduced 13.34%
409,141 $66.1 Million
Q2 2021

Aug 16, 2021

SELL
$159.48 - $171.07 $1.81 Million - $1.94 Million
-11,347 Reduced 2.35%
472,141 $77.8 Million
Q1 2021

May 07, 2021

BUY
$153.07 - $170.48 $5.66 Million - $6.31 Million
37,000 Added 8.29%
483,488 $79.5 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $12.8 Million - $14.7 Million
93,200 Added 26.38%
446,488 $70.3 Million
Q3 2020

Oct 26, 2020

SELL
$140.38 - $153.83 $2.72 Million - $2.98 Million
-19,400 Reduced 5.21%
353,288 $52.6 Million
Q2 2020

Aug 11, 2020

BUY
$128.81 - $155.51 $27.4 Million - $33 Million
212,400 Added 132.51%
372,688 $52.4 Million
Q1 2020

May 08, 2020

SELL
$111.14 - $153.99 $49.7 Million - $68.8 Million
-447,000 Reduced 73.61%
160,288 $21 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $28.5 Million - $32.8 Million
223,700 Added 58.32%
607,288 $88.6 Million
Q3 2019

Oct 23, 2019

BUY
$126.95 - $142.14 $13.1 Million - $14.7 Million
103,300 Added 36.85%
383,588 $49.6 Million
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $5.15 Million - $5.67 Million
39,300 Added 16.31%
280,288 $39 Million
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $3.96 Million - $4.4 Million
31,500 Added 15.04%
240,988 $33.7 Million
Q4 2018

Feb 14, 2019

SELL
$122.84 - $147.84 $1.47 Million - $1.77 Million
-12,000 Reduced 5.42%
209,488 $27 Million
Q3 2018

Nov 16, 2018

SELL
$121.58 - $142.88 $5.47 Million - $6.43 Million
-45,000 Reduced 16.89%
221,488 $30.6 Million
Q2 2018

Aug 15, 2018

BUY
$119.4 - $131.76 $7.56 Million - $8.34 Million
63,300 Added 31.15%
266,488 $32.3 Million
Q1 2018

May 16, 2018

SELL
$125.1 - $148.14 $21.8 Million - $25.8 Million
-174,300 Reduced 46.17%
203,188 $26 Million
Q4 2017

Feb 15, 2018

BUY
$131.22 - $143.62 $21.1 Million - $23.1 Million
161,000 Added 74.37%
377,488 $52.7 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $28 Million - $29.3 Million
216,488
216,488 $28.1 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Alberta Investment Management Corp Portfolio

Follow Alberta Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.